Hikma Pharmaceuticals PLC Annual report 2010 notes to tHe ConsoLIdAted FInAnCIALstAtements Continued 23.
CAsH And CAsH equIvALents As at 31 december 2010 2009 $000 $000 Cash at banks and on hand 50,787 52,107 time deposits 11,931 13,452 money market deposits 104 62,718 65,663 Cash and cash equivalents include highly liquid investments with maturities of three months or less.
BAnk overdrAFts And LoAns As at 31 december 2010 2009 $000 $000 Bank overdrafts 14,462 15,924 Import and export financing 23,844 10,831 short-term loans 6,514 2,323 Current portion of long-term loans note 27 36,195 31,239 81,015 60,317 2010 2009 % % The weighted average interest rates paid were as follows: Bank overdrafts 3.45 3.65 Bank loans including the non-current bank loans 2.95 3.64 Import and export financing 2.76 2.19 Import and export financing represents short-term financing for the ordinary trading activities of the business.
25. trAde And otHer PAyABLes As at 31 december 2010 2009 $000 $000 trade payables 74,936 57,307 Accrued expenses 42,428 35,602 employees provident fund 2,625 4,049 vAt and sales tax payables 452 3,033 dividends payable 2,256 2,348 social security withholdings 1,130 856 Income tax withholdings 2,074 1,456 other payables 1,654 2,967 127,555 107,618 The employees provident fund liability mainly represents the outstanding contributions due to the Hikma Pharmaceuticals Limited Jordan retirement benefit plan, on which the fund receives 5% interest.
Dividends payable includes USD 2,072,000 2009: USD 2,165,000 due to the previous shareholders of APM.
